‘Edarbi’ co-marketed by Takeda Pharmaceuticals & Dong-A ST enters Seoul National University Hospital
‘Edarbi’ jointly sold by Takeda Pharmaceuticals and Dong-A ST has entered Seoul National University Hospital.
At the Drug Committee on the last 2nd, Seoul National University let various drugs, like ‘Edarbi.’ LG Chem’s ‘Zemiro,’ GC Pharm’s ‘IVIG-SN’ and Celltion’s ‘Herzuma,’ pass the committee.
...Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
